Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Prevalence and associated factors of schistosomiasis among pregnant women in northern Senegal

Ndiour CN, Senghor B, Thiam O, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2024; 24 (1) : 1-14.
Download PDF
Publication

WHO Alliance for the Global Elimination of Trachoma: progress report on elimination of trachoma, 2023

World Health Organization . 2024;
Download PDF
Publication

A partnership in progress: Africa and the EU strive for global health and equitable access

Tondel F, Apiko P, Koyier H. ECDPM. 2024;
Download PDF
Publication

Feasibility and acceptability of integrating mass distribution of azithromycin to children 1-11 months into a trachoma mass drug administration campaign to reduce child mortality in Côte d'Ivoire.

Dulli L, Touré F, Mama A, et al. PLOS global public health. 2024; 4 (7) : 1-18.
Download PDF
Publication

Schistosomiasis diagnosis: Challenges and opportunities for elimination.

Ally O, Kanoi B, Ochola L, et al. PLoS neglected tropical diseases. 2024; 18 (7) : 1-16.
Download PDF
Publication

Rocky Mountain spotted fever is a neglected tropical disease in Latin America.

Álvarez-Hernández G, Paddock C, Walker D, et al. PLoS neglected tropical diseases. 2024; 18 (7) : 1-7.
Download PDF
Publication

A comprehensive exploration of schistosomiasis: Global impact, molecular characterization, drug discovery, artificial intelligence and future prospects.

Ekloh W, Asafu-Adjaye A, Tawiah-Mensah C, et al. Heliyon. 2024; 10 (12) : 1-22.
Download PDF
Publication

Using human rights to advance global health justice in an age of inequality

Yamin AE, Robinson J. Public Library of Science (PLoS). PLOS Global Public Health. 2024; 4 (7) : 1-4.
Download PDF
Practical material

Leishmaniasis: information for internally displaced persons and refugees

World Health Organization, Regional office the Eastern Mediterranean . n.d.;
Access resource
Publication

Importance of Integrated Vector Management (IVM) for the Control of Vector Borne Diseases

Mohammed Mosleh Uddin AN, Hasan Jewel M. Journal of Armed Forces Medical College, Bangladesh. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 103
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD